InspireMD, Regulatory Thursday, November 12, 2026 +0.80 Positive

InspireMD gains FDA approval for carotid stent to expand TCAR market

InspireMD received FDA approval for the CGuard Prime TransCarotid Stent System, expected to approximately double the U.S. addressable market. The company reported continued strong international performance and announced key leadership appointments ahead of the U.S. launch.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed